Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Hoek

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Archives of Dermatology|January 23, 2008
Voodoo medicine still going strong: a tale of melanoma, faith, and failureMirjam Beyeler, Keith Hoek, Reinhard Dummer
Cancer Biology & Therapy|October 28, 2005
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomasAmanda Pfaff Smith, Keith Hoek, Dorothea Becker
The Journal of Investigative Dermatology|April 26, 2003
Exploring primary cutaneous B-cell lymphoma by microarray technologyReinhard Dummer, Mirjana Urosevic, Keith Hoek, et al.
Pigment Cell Research|March 21, 2007
Loss of maspin expression contributes to a more invasive potential in malignant melanomaAlexandra E Denk, Marcus Bettstetter, Peter J Wild, et al.
Cancer Research|August 4, 2004
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomasKeith Hoek, David L Rimm, Kenneth R Williams, et al.
Cancer Cell|July 2, 2014
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathwayDirena Alonso-Curbelo, Erica Riveiro-Falkenbach, Eva Pérez-Guijarro, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archives of Dermatology|January 23, 2008
Voodoo medicine still going strong: a tale of melanoma, faith, and failureMirjam Beyeler, Keith Hoek, Reinhard Dummer
Cancer Biology & Therapy|October 28, 2005
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomasAmanda Pfaff Smith, Keith Hoek, Dorothea Becker
The Journal of Investigative Dermatology|April 26, 2003
Exploring primary cutaneous B-cell lymphoma by microarray technologyReinhard Dummer, Mirjana Urosevic, Keith Hoek, et al.
Pigment Cell Research|March 21, 2007
Loss of maspin expression contributes to a more invasive potential in malignant melanomaAlexandra E Denk, Marcus Bettstetter, Peter J Wild, et al.
Cancer Research|August 4, 2004
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomasKeith Hoek, David L Rimm, Kenneth R Williams, et al.
Cancer Cell|July 2, 2014
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathwayDirena Alonso-Curbelo, Erica Riveiro-Falkenbach, Eva Pérez-Guijarro, et al.
Pageof 1